{"pmid":32437942,"title":"International COVID-19 palliative care guidance for nursing homes leaves key themes unaddressed.","text":["International COVID-19 palliative care guidance for nursing homes leaves key themes unaddressed.","COVID-19 mortality disproportionally affects nursing homes, creating enormous pressures to deliver high-quality end-of-life care. Comprehensive palliative care should be an explicit part of both national and global COVID-19 response plans. Therefore, we aimed to identify, review and compare national and international COVID-19 guidance for nursing homes concerning palliative care, issued by government bodies and professional associations. We performed a directed documentary and content analysis of newly developed or adapted COVID-19 guidance documents from across the world. Documents were collected via expert consultation and independently screened against pre-specified eligibility criteria. We applied thematic analysis and narrative synthesis techniques. We identified 21 eligible documents covering both nursing homes and palliative care; from the World Health Organization (n=3), and eight individual countries: USA (n=7), the Netherlands (n=2), Ireland (n=1), United Kingdom (n=3), Switzerland (n=3), New Zealand (n=1), Belgium (n=1). International documents focused primarily on infection prevention and control, including only a few sentences on palliative care related topics. Palliative care themes most frequently mentioned across documents were end-of-life visits, advance care planning documentation, and clinical decision-making towards the end of life (focusing on hospital transfers). There is a dearth of comprehensive international COVID-19 guidance on palliative care for nursing homes. Most have a limited focus both regarding breadth of topics and recommendations made. Key aspects of palliative care, i.e. symptom management, staff education and support, referral to specialist services or hospice, and family support, need greater attention in future guidelines.","J Pain Symptom Manage","Joni, Gilissen","Lara, Pivodic","Unroe Kathleen, T","Lieve, Van den Block","32437942"],"abstract":["COVID-19 mortality disproportionally affects nursing homes, creating enormous pressures to deliver high-quality end-of-life care. Comprehensive palliative care should be an explicit part of both national and global COVID-19 response plans. Therefore, we aimed to identify, review and compare national and international COVID-19 guidance for nursing homes concerning palliative care, issued by government bodies and professional associations. We performed a directed documentary and content analysis of newly developed or adapted COVID-19 guidance documents from across the world. Documents were collected via expert consultation and independently screened against pre-specified eligibility criteria. We applied thematic analysis and narrative synthesis techniques. We identified 21 eligible documents covering both nursing homes and palliative care; from the World Health Organization (n=3), and eight individual countries: USA (n=7), the Netherlands (n=2), Ireland (n=1), United Kingdom (n=3), Switzerland (n=3), New Zealand (n=1), Belgium (n=1). International documents focused primarily on infection prevention and control, including only a few sentences on palliative care related topics. Palliative care themes most frequently mentioned across documents were end-of-life visits, advance care planning documentation, and clinical decision-making towards the end of life (focusing on hospital transfers). There is a dearth of comprehensive international COVID-19 guidance on palliative care for nursing homes. Most have a limited focus both regarding breadth of topics and recommendations made. Key aspects of palliative care, i.e. symptom management, staff education and support, referral to specialist services or hospice, and family support, need greater attention in future guidelines."],"journal":"J Pain Symptom Manage","authors":["Joni, Gilissen","Lara, Pivodic","Unroe Kathleen, T","Lieve, Van den Block"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437942","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jpainsymman.2020.04.151","keywords":["covid-19","long-term care","nursing homes","palliative care"],"locations":["Netherlands","Ireland","United Kingdom","Switzerland","New Zealand","Belgium"],"countries":["Ireland","New Zealand","Belgium","Netherlands","Switzerland","United Kingdom"],"countries_codes":["IRL|Ireland","NZL|New Zealand","BEL|Belgium","NLD|Netherlands","CHE|Switzerland","GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1667521393779015680,"score":9.490897,"similar":[{"pmid":32484912,"title":"Characteristics of U.S. Nursing Homes with COVID-19 Cases.","text":["Characteristics of U.S. Nursing Homes with COVID-19 Cases.","BACKGROUND: COVID-19 has been documented in a large share of nursing homes throughout the United States. This has led to high rates of mortality for residents. In order to understand how to prevent and mitigate future outbreaks, it is imperative that we understand which nursing homes are more likely to experience COVID-19 cases. OBJECTIVE: To examine the characteristics of nursing homes with documented COVID-19 cases in 30 states reporting individual facilities affected. DESIGN AND SETTING: We constructed a database of nursing homes with verified COVID-19 cases as of May 11, 2020 via correspondence with and publicly available reports from state departments of health. We linked this information to nursing home characteristics and used regression analysis to examine association between these characteristics and the likelihood of having a documented COVID-19 case. RESULTS: Of 9,395 nursing homes in our sample, 2,949 (31.4%) had a documented COVID-19 case. Larger facility size, urban location, greater percentage of African American residents, non-chain status, and state were significantly (p<0.05) related to increased probability of having a COVID-19 case. Five-star rating, prior infection violation, Medicaid dependency, and ownership were not significantly related. CONCLUSIONS: COVID-19 cases in nursing homes are related to facility location and size and not traditional quality metrics such as star rating and prior infection control citations. This article is protected by copyright. All rights reserved.","J Am Geriatr Soc","Abrams, Hannah R","Loomer, Lacey","Gandhi, Ashvin","Grabowski, David C","32484912"],"abstract":["BACKGROUND: COVID-19 has been documented in a large share of nursing homes throughout the United States. This has led to high rates of mortality for residents. In order to understand how to prevent and mitigate future outbreaks, it is imperative that we understand which nursing homes are more likely to experience COVID-19 cases. OBJECTIVE: To examine the characteristics of nursing homes with documented COVID-19 cases in 30 states reporting individual facilities affected. DESIGN AND SETTING: We constructed a database of nursing homes with verified COVID-19 cases as of May 11, 2020 via correspondence with and publicly available reports from state departments of health. We linked this information to nursing home characteristics and used regression analysis to examine association between these characteristics and the likelihood of having a documented COVID-19 case. RESULTS: Of 9,395 nursing homes in our sample, 2,949 (31.4%) had a documented COVID-19 case. Larger facility size, urban location, greater percentage of African American residents, non-chain status, and state were significantly (p<0.05) related to increased probability of having a COVID-19 case. Five-star rating, prior infection violation, Medicaid dependency, and ownership were not significantly related. CONCLUSIONS: COVID-19 cases in nursing homes are related to facility location and size and not traditional quality metrics such as star rating and prior infection control citations. This article is protected by copyright. All rights reserved."],"journal":"J Am Geriatr Soc","authors":["Abrams, Hannah R","Loomer, Lacey","Gandhi, Ashvin","Grabowski, David C"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484912","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/jgs.16661","keywords":["covid-19","long-term care","nursing homes"],"locations":["United States","African American"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1668704334382104576,"score":330.75296},{"pmid":32454184,"title":"Development of a Palliative Care Toolkit for the COVID-19 Pandemic.","text":["Development of a Palliative Care Toolkit for the COVID-19 Pandemic.","The COVID-19 pandemic has led to high numbers of critically ill and dying patients in need of expert management of dyspnea, delirium, and serious illness communication. The rapid spread of SARS-CoV-2 creates surges of infected patients requiring hospitalization and puts palliative care programs at risk of being overwhelmed by patients, families, and clinicians seeking help. In response to this unprecedented need for palliative care, our program sought to create a collection of palliative care resources for non-palliative care clinicians. A workgroup of interdisciplinary palliative care clinicians developed the Palliative Care Toolkit, consisting of a detailed chapter in a COVID-19 online resource, a mobile and desktop web application, one-page guides, pocket cards, and communication skills training videos. The suite of resources provides expert and evidence-based guidance on symptom management including dyspnea, pain, and delirium, and also on serious illness communication, including conversations about goals of care, code status, and end-of-life. We also created a nurse resource hotline staffed by palliative care nurse practitioners and virtual office hours staffed by a palliative care attending physician. Since its development, the Toolkit has helped us disseminate best practices to non-palliative care clinicians delivering primary palliative care, allowing our team to focus on the highest-need consults, and increasing acceptance of palliative care across hospital settings.","J Pain Symptom Manage","Thomas, Jane deLima","Leiter, Richard E","Abrahm, Janet L","Shameklis, Jaclyn C","Kiser, Stephanie B","Gelfand, Samantha L","Sciacca, Kate R","Reville, Barbara","Siegert, Callie A","Zhang, Haipeng","Lai, Lucinda","Sato, Rintaro","Smith, Lorie N","Kamdar, Mihir M","Greco, Lauren","Lee, Kathleen A","Tulsky, James A","Lawton, Andrew J","32454184"],"abstract":["The COVID-19 pandemic has led to high numbers of critically ill and dying patients in need of expert management of dyspnea, delirium, and serious illness communication. The rapid spread of SARS-CoV-2 creates surges of infected patients requiring hospitalization and puts palliative care programs at risk of being overwhelmed by patients, families, and clinicians seeking help. In response to this unprecedented need for palliative care, our program sought to create a collection of palliative care resources for non-palliative care clinicians. A workgroup of interdisciplinary palliative care clinicians developed the Palliative Care Toolkit, consisting of a detailed chapter in a COVID-19 online resource, a mobile and desktop web application, one-page guides, pocket cards, and communication skills training videos. The suite of resources provides expert and evidence-based guidance on symptom management including dyspnea, pain, and delirium, and also on serious illness communication, including conversations about goals of care, code status, and end-of-life. We also created a nurse resource hotline staffed by palliative care nurse practitioners and virtual office hours staffed by a palliative care attending physician. Since its development, the Toolkit has helped us disseminate best practices to non-palliative care clinicians delivering primary palliative care, allowing our team to focus on the highest-need consults, and increasing acceptance of palliative care across hospital settings."],"journal":"J Pain Symptom Manage","authors":["Thomas, Jane deLima","Leiter, Richard E","Abrahm, Janet L","Shameklis, Jaclyn C","Kiser, Stephanie B","Gelfand, Samantha L","Sciacca, Kate R","Reville, Barbara","Siegert, Callie A","Zhang, Haipeng","Lai, Lucinda","Sato, Rintaro","Smith, Lorie N","Kamdar, Mihir M","Greco, Lauren","Lee, Kathleen A","Tulsky, James A","Lawton, Andrew J"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454184","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jpainsymman.2020.05.021","topics":["Prevention"],"weight":1,"_version_":1667881798450806785,"score":292.57925},{"pmid":32384004,"title":"Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.","text":["Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.","The Novel Coronavirus SARS-CoV-2 (COVID-19) pandemic is changing how we deliver expert palliative care. We can expect many to die prematurely secondary to COVID-19 across the United States. We present a case of how several hospital systems-based interventions, intended to slow viral spread and to protect health care workers, have inadvertently created barriers to routine palliative interventions in this patient population. Isolation of patients, limitation of visitors and interdisciplinary support, and changes in nursing and provider assessment have all had their impact on how we deliver palliative care. These barriers have altered many aspects of our established workflow and algorithms for care, including changes in communication, goals of care discussions, how providers and nurses are monitoring for symptoms, and end-of-life monitoring. These challenges required real-time solutions such as technology utilization, proposing a change in medical delivery systems, and reducing redundancy to preserve personal protective equipment. To continue to deliver quality care for this patient population, palliative medicine must adapt quickly.","J Palliat Med","Pahuja, Meera","Wojcikewych, Devon","32384004"],"abstract":["The Novel Coronavirus SARS-CoV-2 (COVID-19) pandemic is changing how we deliver expert palliative care. We can expect many to die prematurely secondary to COVID-19 across the United States. We present a case of how several hospital systems-based interventions, intended to slow viral spread and to protect health care workers, have inadvertently created barriers to routine palliative interventions in this patient population. Isolation of patients, limitation of visitors and interdisciplinary support, and changes in nursing and provider assessment have all had their impact on how we deliver palliative care. These barriers have altered many aspects of our established workflow and algorithms for care, including changes in communication, goals of care discussions, how providers and nurses are monitoring for symptoms, and end-of-life monitoring. These challenges required real-time solutions such as technology utilization, proposing a change in medical delivery systems, and reducing redundancy to preserve personal protective equipment. To continue to deliver quality care for this patient population, palliative medicine must adapt quickly."],"journal":"J Palliat Med","authors":["Pahuja, Meera","Wojcikewych, Devon"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32384004","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1089/jpm.2020.0190","keywords":["covid-19","palliative care","patient isolation","symptom assessment","symptom management","system barriers"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666419683263250432,"score":281.09436},{"pmid":32325167,"pmcid":"PMC7169932","title":"Characteristics, symptom management and outcomes of 101 patients with COVID-19 referred for hospital palliative care.","text":["Characteristics, symptom management and outcomes of 101 patients with COVID-19 referred for hospital palliative care.","Hospital palliative care is an essential part of the COVID-19 response but data are lacking. We identified symptom burden, management, response to treatment, and outcomes for a case series of 101 in-patients with confirmed COVID-19 referred to hospital palliative care. Patients (64 male, median [IQR] age 82 [72-89] years, Elixhauser Comorbidity Index 6 [2-10], Australian-modified Karnofsky Performance Status 20 [10-20]), were most frequently referred for end of life care or symptom control. Median [IQR] days from hospital admission to referral was 4 [1-12] days. Most prevalent symptoms (n) were breathlessness (67), agitation (43), drowsiness (36), pain (23) and delirium (24). Fifty-eight patients were prescribed a subcutaneous infusion. Frequently used medicines (median-maximum dose/24h) were opioids (morphine, 10-30mg; fentanyl, 100-200mcg; alfentanil 500-1000 mcg) and midazolam (10-20mg). Infusions were assessed as at least partially effective for 40/58 patients, while 13 patients died before review. Patients spent a median [IQR] of 2 [1-4] days under the palliative care team, who made 3 [2-5] contacts across patient, family and clinicians. At March 30 2020, 75 patients had died, 13 been discharged back to team, home or hospice, and 13 continued to receive inpatient palliative care. Palliative care is an essential component to the COVID-19 response, and teams must rapidly adapt with new ways of working. Breathlessness and agitation are common but respond well to opioids and benzodiazepines. Availability of subcutaneous infusion pumps is essential. An international minimum dataset for palliative care would accelerate finding answers to new questions as the COVID-19 pandemic develops.","J Pain Symptom Manage","Lovell, Natasha","Maddocks, Matthew","Etkind, Simon N","Taylor, Katie","Carey, Irene","Vora, Vandana","Marsh, Lynne","Higginson, Irene J","Prentice, Wendy","Edmonds, Polly","Sleeman, Katherine E","32325167"],"abstract":["Hospital palliative care is an essential part of the COVID-19 response but data are lacking. We identified symptom burden, management, response to treatment, and outcomes for a case series of 101 in-patients with confirmed COVID-19 referred to hospital palliative care. Patients (64 male, median [IQR] age 82 [72-89] years, Elixhauser Comorbidity Index 6 [2-10], Australian-modified Karnofsky Performance Status 20 [10-20]), were most frequently referred for end of life care or symptom control. Median [IQR] days from hospital admission to referral was 4 [1-12] days. Most prevalent symptoms (n) were breathlessness (67), agitation (43), drowsiness (36), pain (23) and delirium (24). Fifty-eight patients were prescribed a subcutaneous infusion. Frequently used medicines (median-maximum dose/24h) were opioids (morphine, 10-30mg; fentanyl, 100-200mcg; alfentanil 500-1000 mcg) and midazolam (10-20mg). Infusions were assessed as at least partially effective for 40/58 patients, while 13 patients died before review. Patients spent a median [IQR] of 2 [1-4] days under the palliative care team, who made 3 [2-5] contacts across patient, family and clinicians. At March 30 2020, 75 patients had died, 13 been discharged back to team, home or hospice, and 13 continued to receive inpatient palliative care. Palliative care is an essential component to the COVID-19 response, and teams must rapidly adapt with new ways of working. Breathlessness and agitation are common but respond well to opioids and benzodiazepines. Availability of subcutaneous infusion pumps is essential. An international minimum dataset for palliative care would accelerate finding answers to new questions as the COVID-19 pandemic develops."],"journal":"J Pain Symptom Manage","authors":["Lovell, Natasha","Maddocks, Matthew","Etkind, Simon N","Taylor, Katie","Carey, Irene","Vora, Vandana","Marsh, Lynne","Higginson, Irene J","Prentice, Wendy","Edmonds, Polly","Sleeman, Katherine E"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325167","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jpainsymman.2020.04.015","keywords":["covid-19","coronavirus","end of life","hospice","palliative care","symptom management"],"locations":["Australian"],"countries":["Australia"],"countries_codes":["AUS|Australia"],"e_drugs":["Morphine","Fentanyl","Benzodiazepines","Midazolam","Alfentanil"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138493917593600,"score":276.24564},{"pmid":32240754,"pmcid":"PMC7171263","title":"Creating a Palliative Care Inpatient Response Plan for COVID-19-The UW Medicine Experience.","text":["Creating a Palliative Care Inpatient Response Plan for COVID-19-The UW Medicine Experience.","CONTEXT: The coronavirus disease 2019 (COVID-19) pandemic is stressing health care systems throughout the world. Significant numbers of patients are being admitted to the hospital with severe illness, often in the setting of advanced age and underlying comorbidities. Therefore, palliative care is an important part of the response to this pandemic. The Seattle area and UW Medicine have been on the forefront of the pandemic in the U.S. METHODS: UW Medicine developed a strategy to implement a palliative care response for a multihospital health care system that incorporates conventional capacity, contingency capacity, and crisis capacity. The strategy was developed by our palliative care programs with input from the health care system leadership. RESULTS: In this publication, we share our multifaceted strategy to implement high-quality palliative care in the context of the COVID-19 pandemic that incorporates conventional, contingency, and crisis capacity and focuses on the areas of the hospital caring for the most patients: the emergency department, intensive care units, and acute care services. The strategy focuses on key content areas, including identifying and addressing goals of care, addressing moderate and severe symptoms, and supporting family members. CONCLUSION: Strategy planning for delivery of high-quality palliative care in the context of the COVID-19 pandemic represents an important area of need for our health care systems. We share our experiences of developing such a strategy to help other institutions conduct and adapt such strategies more quickly.","J Pain Symptom Manage","Fausto, James","Hirano, Lianne","Lam, Daniel","Mehta, Amisha","Mills, Blair","Owens, Darrell","Perry, Elizabeth","Curtis, J Randall","32240754"],"abstract":["CONTEXT: The coronavirus disease 2019 (COVID-19) pandemic is stressing health care systems throughout the world. Significant numbers of patients are being admitted to the hospital with severe illness, often in the setting of advanced age and underlying comorbidities. Therefore, palliative care is an important part of the response to this pandemic. The Seattle area and UW Medicine have been on the forefront of the pandemic in the U.S. METHODS: UW Medicine developed a strategy to implement a palliative care response for a multihospital health care system that incorporates conventional capacity, contingency capacity, and crisis capacity. The strategy was developed by our palliative care programs with input from the health care system leadership. RESULTS: In this publication, we share our multifaceted strategy to implement high-quality palliative care in the context of the COVID-19 pandemic that incorporates conventional, contingency, and crisis capacity and focuses on the areas of the hospital caring for the most patients: the emergency department, intensive care units, and acute care services. The strategy focuses on key content areas, including identifying and addressing goals of care, addressing moderate and severe symptoms, and supporting family members. CONCLUSION: Strategy planning for delivery of high-quality palliative care in the context of the COVID-19 pandemic represents an important area of need for our health care systems. We share our experiences of developing such a strategy to help other institutions conduct and adapt such strategies more quickly."],"journal":"J Pain Symptom Manage","authors":["Fausto, James","Hirano, Lianne","Lam, Daniel","Mehta, Amisha","Mills, Blair","Owens, Darrell","Perry, Elizabeth","Curtis, J Randall"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240754","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jpainsymman.2020.03.025","keywords":["covid-19","palliative care","pandemic","strategic planning"],"locations":["Seattle","USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138490446807040,"score":272.8059}]}